United Therapeutics Corporation (UTHR) Financial Statements (2024 and earlier)

Company Profile

Business Address 1000 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,8391,9311,8351,4861,416927
Cash and cash equivalents961895739738669705
Short-term investments1,8781,0361,096748747222
Receivables220199157151176297
Inventory, net of allowances, customer advances and progress billings102948793101108
Inventory102948793101108
Other current assets2191008813475116
Total current assets:3,3802,3242,1671,8651,7681,448
Noncurrent Assets
Property, plant and equipment862781732739700546
Long-term investments and receivables1,3161,6501,150768443503
Long-term investments1,3161,6501,150768443503
Intangible assets, net (including goodwill), including:454515815817146
Goodwill 282828283214
Intangible assets, net (excluding goodwill) (6)(6)(6)(5)(5)(9)
Other undisclosed intangible assets, net (including goodwill)222213613614441
Deferred income tax assets328262239230
Other noncurrent assets114108170155224224
Deferred tax assets, net96113
Total noncurrent assets:2,6642,8462,4482,0491,6331,432
TOTAL ASSETS:6,0455,1694,6153,9133,4012,879
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities230175187148166171
Accounts payable 44410238
Accrued liabilities 226171183139143163
Other undisclosed accounts payable and accrued liabilities      
Debt   252  
Other liabilities332840403834
Other undisclosed current liabilities81102972372240
Total current liabilities:343305323463277445
Noncurrent Liabilities
Long-term debt and lease obligation800800800600  
Long-term debt, excluding current maturities800800800600  
Liabilities, other than long-term debt10510597706764
Other liabilities10510597706764
Other undisclosed noncurrent liabilities     250250
Total noncurrent liabilities:905905897670317314
Total liabilities:1,2481,2101,2201,133593758
Temporary equity, carrying amount     1919
Equity
Equity, attributable to parent4,7973,9593,3952,7802,7892,102
Common stock111111
Treasury stock, value(2,579)(2,579)(2,579)(2,579)(2,579)(2,579)
Additional paid in capital2,3882,2452,1492,0481,9401,854
Accumulated other comprehensive loss(56)(23)(14)(14)(8)(20)
Retained earnings5,0424,3153,8393,3253,4352,846
Total equity:4,7973,9593,3952,7802,7892,102
TOTAL LIABILITIES AND EQUITY:6,0455,1694,6153,9133,4012,879

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues1,9361,6861,4831,4491,6281,725
Revenue, net1,725
Cost of revenue(634)(590)(359)(391)(199)(315)
Cost of goods and services sold(152)(123)(108)(118)(199)(106)
Other undisclosed gross profit482467    
Gross profit:1,7851,5631,1241,0581,4291,410
Operating expenses(323)(540)(531)(1,245)(624)(595)
Other undisclosed operating loss(482)(467)    
Operating income (loss):980556594(188)805815
Nonoperating income (expense)(29)384523(47)(45)
Investment income, nonoperating4517294429(50)
Other nonoperating income (expense)(40)424923(8)13
Interest and debt expense(32)(19)(24)(44)(14)(9)
Income (loss) from continuing operations before equity method investments, income taxes:918575615(209)745761
Other undisclosed income from continuing operations before income taxes32192444149
Income (loss) from continuing operations before income taxes:951594639(165)759770
Income tax expense (benefit)(223)(118)(124)61(170)(352)
Income (loss) from continuing operations:727476515(105)589418
Income (loss) before gain (loss) on sale of properties:476515(105)589418
Net income (loss) available to common stockholders, diluted:727476515(105)589418

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):727476515(105)589418
Other comprehensive income 196   1
Other undisclosed comprehensive income      
Comprehensive income (loss):747482515(105)589419
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(52)(15) (6)12(4)
Comprehensive income (loss), net of tax, attributable to parent:695467515(111)601415

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: